Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage — Stella

Home/Postpartum Hemorrhage/Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage

View on ClinicalTrials.gov

Recruiting

Back to Postpartum Hemorrhage trials

Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

China

Renji Hospital, Shanghai Jiaotong University, School of Medcine, Shanghai, Shanghai Municipality

Key details

Phase

Post-approval study

Sponsor

RenJi Hospital

Enrollment target

~276 participants

Started

January 2025

Primary completion

January 2027

Age range

18 Years – 50 Years

Sex

Female only

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.